PENGARUH ECONOMIC VALUE ADDED, RETURN ON ASSETS, DAN DEBT TO EQUITY RATIO TERHADAP HARGA SAHAM PADA PERUSAHAAN FARMASI DI BEI

Abstract

This research aimed to find out and examine the effect of Economic Value Added, Return on Asset, and Debt to Equity Ratio on the stock price of the pharmaceutical companies at IDX. The research was quantitative. Moreover, the population was pharmaceutical companies listed on the Indonesian Stock Exchange (IDX). The data collection technique used saturated sampling with the determined criteria. In line with that, there were 8 Pharmaceutical companies as the sample. Furthermore, the data was taken during 5 years (2018-2022). The data analysis technique used multiple linear regression with SPSS 26 version. The result indicated that Economic Value Added had a negative but insignificant effect on the stock price of the pharmaceutical companies at IDX. However, Return on Asset had a negative and significant effect on the stock price of the pharmaceutical companies at IDX. Likewise, Debt to Equity Ratio had a negative and significant effect on the stock price of the pharmaceuticals companies at IDX.